Author:
Yamashita Jun,Tanaka Nobuhiro,Hokama Yohei,Hoshino Kou,Murata Naotaka,Ogawa Masashi,Kimura Yo,Yamashina Akira
Publisher
The Japanese Coronary Association
Reference11 articles.
1. 1)Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, Yang JY, Lee SG, Kim KS, Yoon J, Jeong MH, Seung KB, Hong TJ, Park SJ; ZEST-AMI Investigators: Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Am J Cardiol 2009; 104: 1370–1376
2. Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions
3. The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents
4. 4)Yamashita J, Tanaka N, Takazawa K, Akasaka T, Oikawa Y, Kataoka T, Takayama T, Tamita K, Fujita H: Neointimal proliferation after deployment of paclitaxel eluting stent had less severe impact on coronary flow. Circ J 2010; 74 suppl I: 436 abstract
5. Neointimal coverage of stents in human coronary arteries observed by angioscopy